Nuvation Bio Inc. (NUVB) Total liabilities 2023–2025
Nuvation Bio Inc. (NUVB) total liabilities at each fiscal year-end, per SEC filings.
$289.1MFY2025 · since FY2023: $16.4M → $289.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $289.1M | +276.3% |
| FY2024 | $76.8M | +369.6% |
| FY2023 | $16.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NUVB financial trends
NUVB RevenueNUVB Net incomeNUVB Net marginNUVB Gross profitNUVB Gross marginNUVB Operating incomeNUVB Operating marginNUVB Operating cash flowNUVB Free cash flowNUVB Capital expendituresNUVB Return on equityNUVB Stock buybacksNUVB Dividends paidNUVB Total assetsNUVB Shareholders’ equityNUVB overview →